ARTICLE | Clinical News
Spiros albuterol, beta agonist bronchodilator: Completed Phase III trial dosing
March 10, 1999 8:00 AM UTC
Dura Pharmaceuticals Inc. (DURA), San Diego, Calif. Product: Spiros albuterol, beta agonist bronchodilator Indication: Asthma Status: DURA completed patient dosing in the placebo-controlled, double-bl...